Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia (PJP) in Patients With Autoimmune Inflammatory Rheumatic Disease (AIIRD)

NCT06499233 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06499233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06499233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia (PJP) in Patients With Autoimmune Inflammatory Rheumatic Disease (AIIRD)
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
July 20, 2024
Completion date
December 31, 2026
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, autoimmune inflammatory rheumatic disease, connective tissue disease, pneumonia, pneumocystis, prevention